InsiderOther

Catherine M. Szyman Insider Trading Activity

Every SEC Form 4 transaction reported by Catherine M. Szyman, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · SEC Form 4 & insider trading data analysts
Last updated:

Quick Answer

Is Catherine M. Szyman buying or selling?

Catherine M. Szyman reported 1 open-market buys ($533.7K) and 53 sells ($42.1M) across 54 Form 4 filings at 2 companies — a net selling position of $41.6M.

Source: SEC EDGAR Form 4

Key Statistics (as of Feb 15, 2024)

Total Form 4 filings
54
SEC EDGAR
Companies
2
Buys (1)
$533.7K
Sells (53)
$42.1M

Insider sentiment

Net selling

Net insider flow of $41.6M in net selling, filed between May 24, 2018 – Feb 15, 2024.

Companies Catherine M. Szyman files for

#CompanyForm 4 filings
1EWEdwards Lifesciences Corp53
2NARIInari Medical, Inc.1

Recent Catherine M. Szyman transactions

DateTickerRoleTypeSharesValue
Feb 15, 2024EWCVP, Critical CareSale47.0K$4.0M
Oct 10, 2023EWCVP, Critical CareSale5.0K$363.4K
Sep 8, 2023EWCVP, Critical CareSale5.0K$380.0K
Aug 9, 2023EWCVP, Critical CareSale5.0K$393.2K
Jul 10, 2023EWCVP, Critical CareSale5.0K$452.6K
Jun 14, 2023EWCVP, Critical CareSale5.0K$429.0K
May 9, 2023EWCVP, Critical CareSale75.6K$6.7M
May 5, 2022EWCVP, Critical CareSale23.4K$2.5M
Apr 11, 2022EWCVP, Critical CareSale20.0K$2.4M
Mar 14, 2022EWCVP, Critical CareSale20.0K$2.1M
Feb 19, 2022EWCVP, Critical CareSale20.0K$2.1M
Jan 15, 2022EWCVP, Critical CareSale10.0K$1.2M
Dec 18, 2021EWCVP, Critical CareSale10.0K$1.2M
Nov 19, 2021EWCVP, Critical CareSale10.0K$1.2M
Oct 18, 2021EWCVP, Critical CareSale9.7K$1.1M
Sep 9, 2021EWCVP, Critical CareSale9.7K$1.2M
Aug 3, 2021EWCVP, Critical CareSale15.0K$1.7M
Jun 16, 2021EWCVP, Critical CareSale3.4K$345.0K
May 28, 2021EWCVP, Critical CareSale2.1K$196.4K
May 25, 2021EWCVP, Critical CareSale4.7K$448.3K
May 7, 2021EWCVP, Critical CareSale3.4K$311.3K
Apr 23, 2021EWCVP, Critical CareSale3.4K$319.9K
Mar 15, 2021EWCVP, Critical CareSale3.4K$276.7K
Feb 17, 2021EWCVP, Critical CareSale3.4K$298.9K
Jan 16, 2021EWCVP, Critical CareSale3.4K$295.8K

Showing the 25 most recent filings of 54. Screen every filing.

Catherine M. Szyman insider trading FAQ

Is Catherine M. Szyman buying or selling?

Across 54 SEC Form 4 filings, Catherine M. Szyman reported 1 open-market purchases totaling $533.7K and 53 sales totaling $42.1M — a net selling position of $41.6M.

Which companies does Catherine M. Szyman file Form 4s for?

Catherine M. Szyman has reported insider transactions at 2 companies, most often Edwards Lifesciences Corp (EW), Inari Medical, Inc. (NARI).

How far back does Catherine M. Szyman's filing history go?

Trabud holds Catherine M. Szyman's SEC Form 4 filings from May 24, 2018 – Feb 15, 2024, sourced directly from SEC EDGAR.

Where does Trabud get Catherine M. Szyman's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track Catherine M. Szyman and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener